Skip to main content
Lepu Biopharma Co., Ltd. logo

Lepu Biopharma Co., Ltd. — Investor Relations & Filings

Ticker · 2157 ISIN · CNE100004SM4 HKEX Manufacturing
Open in API
Filings indexed 240 across all filing types
Latest filing 2022-06-21 Declaration of Voting R…
Country HK Hong Kong
Listing HKEX 2157

About Lepu Biopharma Co., Ltd.

http://www.lepubiopharma.com

Lepu Biopharma Co., Ltd. is an innovation-driven biopharmaceutical company dedicated exclusively to the research and development of oncology therapeutics. The company focuses on advanced tumor treatment modalities, including targeted therapy and cancer immunotherapy. Its strategically built product pipeline encompasses a range of candidate drugs, notably Antibody-Drug Conjugates (ADCs), immunotherapies, and oncolytic virus drugs, with assets spanning clinical and preclinical development stages. Lepu Biopharma leverages its proprietary ADC technology platform to drive the development of innovative treatments. The company pursues domestic commercialization through dedicated sales infrastructure while actively seeking global market access, particularly in the US and European markets, via strategic partnerships and out-licensing agreements for its drug candidates.

Recent filings

Filing Released Lang Actions
POLL RESULTS OF THE 2021 ANNUAL GENERAL MEETING HELD ON JUNE 21, 2022
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is an announcement of the poll results from the 2021 Annual General Meeting (AGM) held on June 21, 2022. It details the voting outcomes on various resolutions including approval of the annual report, financial accounts, profit distribution plan, re-appointment of auditors, and a general mandate to issue shares. The document explicitly states it is announcing the poll results of the AGM, not the full AGM report or annual report itself. The length is about 5857 characters, which is relatively short and focused on voting results. This fits the definition of a Declaration of Voting Results & Voting Rights Announcements (DVA) rather than the full Annual Report (10-K) or AGM Information (AGM-R).
2022-06-21 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2022
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return for Equity Issuer and Hong Kong Depositary Receipts listed under Chapter 19B of the Exchange Listing Rules on Movements in Securities' for the month ended 31 May 2022. It details movements in authorised/registered share capital, issued shares, and confirms compliance with listing rules. The content focuses on share capital and share movements, with no financial statements or earnings data. It is a regulatory submission to the Hong Kong Exchanges and Clearing Limited, reporting share capital and share issuance status. This type of document is a regulatory filing related to share capital movements and confirmations, not a full financial report or announcement of voting results. It fits best under Regulatory Filings (RNS) as a general compliance and disclosure document.
2022-06-01 English
Proxy Form for the Annual General Meeting to be held on 21 June 2022
AGM Information Classification · 100% confidence The document is a proxy form for the Annual General Meeting (AGM) of Lepu Biopharma Co., Ltd. It includes instructions for shareholders to appoint proxies to vote on resolutions at the AGM, including approval of the annual report, financial accounts, profit distribution, auditor re-appointment, and share issuance mandate. The document is not the actual annual report or financial statements but a form related to the AGM process. It is a meeting-related material, specifically proxy voting instructions for the AGM. Therefore, it fits the category of AGM Information (AGM-R). The document length (6150 characters) and content confirm it is not a brief announcement or certification but a substantive proxy form for the AGM.
2022-05-27 English
(1) 2021 REPORT OF THE BOARD OF DIRECTORS (2) 2021 REPORT OF THE BOARD OF SUPERVISORS (3) 2021 ANNUAL REPORT (4) 2021 FINANCIAL ACCOUNTS REPORT (5) 2022 FINANCIAL BUDGET (6) 2021 ANNUAL PROFIT DISTRIB
AGM Information Classification · 100% confidence The document is a circular for the 2021 Annual General Meeting (AGM) of Lepu Biopharma Co., Ltd. It includes the notice of the AGM, details of resolutions to be voted on, including approval of the 2021 Annual Report, Board of Directors and Supervisors reports, financial accounts, profit distribution plan, re-appointment of auditor, and a general mandate to issue shares. The document also contains precautionary measures for the AGM and proxy instructions. It is not the actual annual report or financial statements but a meeting circular providing information for shareholders to make informed decisions at the AGM. Therefore, it fits the category of AGM Information (AGM-R).
2022-05-27 English
NOTICE OF 2021 ANNUAL GENERAL MEETING
AGM Information Classification · 95% confidence The document is a notice for the 2021 Annual General Meeting (AGM) of Lepu Biopharma Co., Ltd. It includes details about the meeting date, location, agenda items such as approval of the annual report, financial accounts, profit distribution plan, and re-appointment of auditors. It also contains procedural notes about voting and proxy appointments. The document does not contain the actual annual report or financial statements but is an announcement of the AGM and its agenda. Therefore, it fits the category of AGM Information (AGM-R). The document length is 6327 characters, which is consistent with a detailed notice but not a full report.
2022-05-27 English
ARTICLES OF ASSOCIATION
Governance Information Classification · 100% confidence The document is titled 'Articles of Association' for Lepu Biopharma Co., Ltd. It contains detailed chapters on company governance, share issuance, board structure, shareholder meetings, financial accounting system, and other corporate governance matters. The content is a comprehensive set of internal rules and regulations governing the company’s organization and conduct, rights and obligations of shareholders, directors, supervisors, and senior management. It is not a financial report, earnings release, or announcement but a governance document. Therefore, it fits the category of Governance Information (CGR). The document length is substantial and contains the full text of the Articles of Association, not just an announcement or summary.
2022-05-27 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.